Health technology

On this edition of ST, we learn about Tulsa Innovation Labs, or TIL, which, per its website, "was founded to develop a city-wide strategy that positions Tulsa as a tech hub and leader in the future of work.

(Note: This interview first aired last summer.) Our guest on ST Medical Monday is Dr. Adam S. Cifu; he's the co-author of an interesting book about "medical reversal" -- i.e., what happens when doctors start using a medication, procedure, or diagnostic tool without a robust evidence base...and then stop using it when it's found not to help, or even to harm, patients.

On this edition of StudioTulsa, we meet investigative journalist John Carreyrou, a two-time Pulitzer winning reporter with the Wall Street Journal, who broke the story of the fraud perpetrated by the medical tech company Theranos and its young CEO Elizabeth Holmes. The company had purportedly created a device that would revolutionize blood testing, utilizing just a few drops of blood, but was found to be a sham. At its peak, Theranos had a market value of $10 billion and its flawed prototype was actually in market testing in California and Arizona before Carreyrou helped expose the fraud.